Clinical trial

Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments, Using Multiomics

NCT05736029

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2022-11-07

PhaseN/A

Study timeline

Study start (actual)2022-11-07Date precision: day

Registry last updated2023-02-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non Small Cell Lung Cancerunresolved

Healthyunresolved

Interventions

blood, stool and tissue samples collectionOTHER

Sponsors & collaborators

OncoHost Ltd.lead sponsor

Mapped research locations

DallasTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05736029 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.